Regarding the effects of survivin on T lymphocytes, Sharief et al. [164] showed that survivin is upregulated in T lymphocytes from patients with multiple sclerosis, and treatment with interferon β-1a leads to the reduction in clinical exacerbations. The gene discussed is BIRC5; the disease is multiple sclerosis.